MYCN-amplified NB tumor specimens express higher levels of CHK1 mRNA than non-MYCN-amplified NB cells [14], suggesting that the sensitivity of such NB cells to CHK1 inhibition may be related to high levels of MYCN-induced RS. The gene discussed is CHEK1; the disease is neoplasm.